Investing in Infinium pharmachem SME IPO! Here is Why?

Infinium pharmachem SME IPO, Infinium pharmachem IPO, Infinium pharmachem IPO Details, Infinium pharmachem IPO Review, Infinium pharmachem IPO Date
Infinium pharmachem SME IPO

Infinium pharmachem IPO subscription is opening up on 31st March 2023 till 5th April 2023. According to the prospectus, the IPO consists of a total of 1,875,000 shares aggregating up to ₹25.31 Cr. The Equity Shares have a face value of Rs 10 each.

Infinium pharmachem IPO The Company Business Description

Incorporated on November 21st, 2003, Infinium pharmachem is engaged in manufacturing and supplying Iodine, Iodine Derivatives, and Active Pharmaceutical Ingredients (APIs).

The Company also offers Contract Research and Manufacturing Services (CRAMS) to provide customized and fully confidential solutions to its clients.

Infinium pharmachem products cater to various industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics, and much more.

The company offers the widest range of Iodine derivatives with more than 250+ intermediates and 15+ APIs.

The company operates in China through its subsidiaries Shanghai Tajilin Industrial Co. Ltd to deal with the API requirements in China. This is a joint venture (JV) with Shanghai Witofly Chemical Co. Ltd.

Infinium pharmachem SME IPO, Infinium pharmachem IPO, Infinium pharmachem IPO Details, Infinium pharmachem IPO Review, Infinium pharmachem IPO Date
Infinium pharmachem IPO

Infinium pharmachem Limited Founders and Leadership team

Mr. Sanjay Viththalbhai Patel, Mr. Pravin Bhadabhai Madhani, and Mr. Mitesh Lavjibhai Chikhaliya are the promoters of the company.

Infinium pharmachem Limited Revenue and Profit

Infinium pharmachem IPO has been generating strong revenue from operations over the years. The total revenue of the company has increased from Rs. 3884.19 lakhs in FY2020 to Rs 9911.93 lakhs in FY2022.

For the Period ended September 30, 2022, the company registered total revenue of Rs. 7927.59 lakhs which are quite significant in terms of annual revenue. The profit after tax reached Rs. 600 lakhs by September 30, 2022, from Rs. 86.78 lakhs in FY 2020.

Infinium pharmachem SME IPO Review : Financial Snapshot

All amounts in INR Lakhs
(Year ended March 31)
FY 2020FY 2021FY 2022Half Year
By Sept,

Revenue Operation3884.197053.079911.937927.59
Total Income3941.647115.3710005.257985.39
Profit for the period86.78272.99668.57600.14
Earnings Per equity Share-Diluted9.1926.8060.0710.84
Net Cash from Operating Activities303.13728.701,179.57194.88
Total Borrowings566.17579.471,385.011614.71
Net Worth424.74702.321310.221855.77
Net Asset Value/Book Value per Equity share41.7869.08128.8836.51

Objective Behind the Infinium pharmachem IPO

Infinium pharmachem is planning to utilize the net proceeds as below.

  • Marketing and Branding Expenses (including Registration in Reach – Europe, and other marketing expenses)
  • Repayment of some of the Existing Loans
  • Expansion of Existing Unit
  • To Meet Incremental Working Capital Requirements
  • General Corporate Purpose

 Infinium pharmachem IPO: Do you invest?

  • Infinium Pharmachem is financially strong with positive net cash inflow from operation activities over the years mentioned in RHP.
  • Earning per share has also been increasing over the years.
  • The company is into Contract Research and Manufacturing Services and pharma API business, for which demand is high in India.
  • The company also has a JV with a Chinese company in Shanghai that will help to cater the China API market.
  • Government of India is promoting pharma API industry through PLI scheme, that will benefit this company.
  • I would love to invest in the company for short to medium term.
  • However, looking at the current scenario where, stock market is volatile, it is wise as a retail investor to avoid investing in IPOs till the market stabilize.

Infinium pharmachem IPO Details

Infinium pharmachem IPO DetailsInfinium pharmachem IPO Date,
Price and other details
Infinium pharmachem IPO DateMar 31, 2023 to Apr 5, 2023
IPO Price ₹135 per share
IPO Allotment dateApr 11, 2023
Refunds Initiation dateApr 12, 2023
Credit of Shares to Demat AccountApr 13, 2023
IPO Listing DateApr 17, 2023
Offer for SaleNil
Fresh Issue1,875,000 shares
(aggregating up to ₹25.26 Cr)
IPO Issue Size
(Fresh Issue)
(aggregating up to ₹25.26 Cr)
Minimum bid (lot size)    
For retail investor                                                 
1 lot of 1000 shares
Investment of ₹135,000
Maximum bid (lot size)    
For retail investor 
1 lot of 1000 shares
Investment of ₹135,000
Retail Shares OfferedNot less than 50% of the Net Offer
Minimum bid (lot size) 
HNI investor
2 lot of 1000 shares (2000)
Investment of ₹270,000
NII (HNI) Shares Offered
Face ValueINR 10 per share
Listing on NSE SME
PromotersMr. Sanjay Viththalbhai Patel,
Mr. Pravin Bhadabhai Madhani,
and Mr. Mitesh Lavjibhai Chikhaliya
are the Promoters

Infinium pharmachem IPO: Lead Managers and Contact

Contact DetailsInfinium pharmachem IPO
Lead Managers
Infinium Pharmachem Limited
38 G.I.D.C Sojitra,
Taluka – Sojitra,
Dist. – Anand – 387240
Phone: +91-2692-238849
Email Id:
Phoner: +91-22-26254568-69
/ 0731-6644244

Infinium pharmachem SME IPO Allotment Status

Infinium pharmachem SME IPO Allotment status will be available on Bigshare Services Pvt Ltd. To know your allotment status, get ready with your PAN number and click on this link. You may also reach out to Phone: 011-40450193-197, Facsimile: 011-26812683 Email:;

More Across from our Website

We endeavor to help you to understand different aspects of a company before you invest in the company’s IPO, India IPO Trends 2023, New Companies in the Indian share market 2023. To know more information about business overview of each company, here are some suggested readings on company insights for investment – 10 Best IPOs in 2022Tata Play IPOUpcoming IPOsUpcoming SME IPOs.